References
-
1
Weck M N, Stegmaier C, Rothenbacher D. et al .
Epidemiology of chronic atrophic gastritis: population-based study among 9444 older adults from Germany.
Aliment Pharmacol Ther.
2007;
26
879-887
-
2
Miki K, Ichinose M, Shimizu A. et al .
Serum pepsinogens as a screening test of extensive chronic gastritis.
Gastroenterol Jpn.
1987;
22
133-141
-
3
Samloff I M, Varis K, Ihamaki T. et al .
Relationships among serum pepsinogen I, serum pepsinogen II, and gastric mucosal histology. A study in relatives of patients with pernicious anemia.
Gastroenterology.
1982;
83
204-209
-
4
Webb P M, Hengels K J, Moller H. et al .
The epidemiology of lower serum pepsinogen A levels and an international association with gastric cancer rates. EUROGAST Study Group.
Gastroenterology.
1994;
107
1335-1344
-
5
Checchi S, Montanaro A, Pasqui L. et al .
Serum ghrelin as a marker of atrophic body gastritis in patients with parietal cell antibodies.
J Clin Endocrinol Metab.
2007;
92
4346-4351
-
6
Shiotani A, Uedo N, Iishi H. et al .
Re-expression of sonic hedgehog and reduction of CDX2 after Helicobacter pylori eradication prior to incomplete intestinal metaplasia.
Int J Cancer.
2007;
121
1182-1189
-
7
Zavros Y, Waghray M, Tessier A. et al .
Reduced pepsin A processing of sonic hedgehog in parietal cells precedes gastric atrophy and transformation.
J Biol Chem.
2007;
282
33 265-33 274
-
8
Shiotani A, Iishi H, Uedo N. et al .
Helicobacter pylori-induced atrophic gastritis progressing to gastric cancer exhibits sonic hedgehog loss and aberrant CDX2 expression.
Aliment Pharmacol Ther.
2006;
24 (Suppl 4)
71-80
-
9
Wong B C, Lam S K, Wong W M. et al .
Helicobacter pylori eradication to prevent gastric cancer in high-risk region of China: a randomized controlled trial.
JAMA.
2004;
291
187-194
-
10
Ravizza M.
Does Helicobacter pylori eradication modify intestinal metaplasia evolution in the stomach?.
Minerva Gastroenterol Dietol.
2002;
48
165-167
-
11
Koussoulas V, Tzivras M, Giamarellos-Bourboulis E J. et al .
Can soluble triggering receptor expressed on myeloid cells (sTREM-1) be considered an anti-inflammatory mediator in the pathogenesis of peptic ulcer disease?.
Dig Dis Sci.
2007;
52
2166-2169
-
12
Koussoulas V, Vassiliou S, Demonakou M. et al .
Soluble triggering receptor expressed on myeloid cells (sTREM-1): a new mediator involved in the pathogenesis of peptic ulcer disease.
Eur J Gastroenterol Hepatol.
2005;
18
375-379
-
13
Bodger K, Bromelow K, Wyatt J I. et al .
Interleukin-10 in Helicobacter pylori associated gastritis: immunohistochemical localization and in vitro effects in cytokines secretions.
J Clin Pathol.
2001;
54
285-292
-
14
Koussoulas V, Vassiliou S, Spyridaki E. et al .
Evidence for the role of gastric mucosa at the secretion of soluble triggering receptor expressed on myeloid cells (strem-1) in peptic ulcer disease.
World J Gastroenterol.
2007;
13
4610-4614
-
15
Ray W A, Chung C P, Stein C M. et al .
Risk of peptic ulcer hospitalizations in users of NSAIDs with gastroprotective cotherapy versus coxibs.
Gastroenterology.
2007;
133
790-798
-
16
Laine L.
Nonsteroidal anti-inflammatory durg gastropathy.
Gastrointest Endsc Clin N Am.
1996;
6
489-501
-
17
Laine L, Harper S, Simon T. et al .
A randomized trial comparing the effect of rofecoxib, a COX-2 specific inhibitor, to ibuprofen on the gastroduodenal mucosa of osteoarthritis patients.
Gastroenterolgy.
1999;
117
776-783
-
18
Rostom A, Muir K, Dube C. et al .
Gastrointestinal safety of cyclooxygenase-2 inhibitors: a Cochrane Collaboration Systematic Review.
Clin Gastroenterol Hepatol.
2007;
5
818-828
-
19
Laine L, Takeuchi K, Tarnawski A.
Gastric mucosal defense and cytoprotection: bench to bedside.
Gastroenterology.
2008;
135
41-60
-
20
Robson A J, Richards J M, Ohly N. et al .
The effect of surgical subspecialization on outcomes in peptic ulcer disease complicated by perforation and bleeding.
World J Surg.
2008;
32
1456-1461
-
21
Zaragoza A M, Tenias J M, Llorente M J. et al .
Prognostic factors in gastrointestinal bleeding due to peptic ulcer: construction of a predictive model.
J Clin Gastroenterol.
2008;
42
786-790
-
22
Larssen L, Moger T, Bjornbeth B A. et al .
Transcatheter arterial embolization in the management of bleeding duodenal ulcers: a 5.5-year retrospective study of treatment and outcome.
Scand J Gastroenterol.
2008;
43
217-222
-
23
Imhof M, Epstein S, Ohmann C. et al .
Duration of survival after peptic ulcer perforation.
World J Surg.
2008;
32
408-412
H. KashiwagiMD
Department of Surgery
Jikei University School of Medicine
3-25-8, Nishi-shinbashi
Minato-ku
Tokyo
Japan
Fax: +81-3-54724140
eMail: hkashiwagi.surg@jikei.ac.jp
